猫用ワクチン市場レポート：動向、予測、競合分析 (2031年まで)

世界の猫用ワクチン市場の将来は、動物病院、ペットショップ、オンライン小売業者のチャネルにおける機会で有望視されています。世界の猫用ワクチン市場は、2025年から2031年までのCAGRが7.2%で、2031年までに推定19億米ドルに達すると予想されています。この市場の主な促進要因は、猫の飼育数の増加と、猫が媒介する病気を予防するためのワクチン接種に対する大きな需要です。

• Lucintelの予測では、技術カテゴリーでは、高効率で抗体免疫反応と細胞性免疫反応の両方を刺激する能力を持つ弱毒生ワクチンが引き続き最大セグメントとなります。
• 販売チャネルのカテゴリーでは、動物病院が予測期間中に最も高い成長を遂げると予想されます。
• 地域別では、猫を深刻な病気から守るためのワクチン接種に関する政府の規制が厳しいことと、米国での猫の飼育率が上昇していることから、北米が引き続き最大の地域となります。

猫用ワクチン市場の戦略的成長機会

猫用ワクチンの市場成長は、技術の進歩、ペット飼育の増加、猫の健康に対する意識に後押しされ、主要なアプリケーションに多くの戦略的機会を提供しています。

• 予防ワクチン接種の増加：予防ワクチン接種プログラムの増加は、成長機会をもたらします。ワクチンの利点に対する意識の高まりにより、猫の疾病に対するカバー率の向上と発生頻度の減少が求められています。
• 高度なワクチン製剤の開発：混合ワクチンや個別化ワクチンを含む新世代のワクチンは、全く新しい市場セグメントを開拓する可能性があります。これらのブレークスルーは特定の健康ニーズに対応し、ワクチンの有効性を向上させ、市場成長にプラスの影響を与えます。
• ワクチン送達方法の革新：点鼻薬や経口ワクチンなど、ワクチン接種のための新たな戦略が開発されています。これにより、ワクチンの受容率や投与率が向上し、この技術が主流になる可能性が高まると予想されます。
• 新興市場の成長：ペットの飼育が増加している新興市場への進出は、拡大の余地が大きいです。こうした地域に適したソリューションをカスタマイズすることで、この市場スペースでより大きなシェアを獲得することができます。
• ネコの健康調査への注力：新たなネコの病気に対するワクチン開発を目的とした研究への投資は、成長の可能性を秘めています。新たな健康上の脅威に対処し、既存のワクチンを改良することで、市場競争力と革新性を高めることができます。

こうした要因により、予防医療、技術の進歩、市場の拡大に重点を置いた猫用ワクチン市場が形成されつつあります。

猫用ワクチン市場の促進要因・課題

猫用ワクチン市場は、技術進歩、経済要因、規制変更など、いくつかの市場促進要因・課題の影響を受けます。したがって、これらの要素を理解することは、市場情勢をナビゲートする上で極めて重要です。

猫用ワクチン市場を牽引する要因は以下の通りです：

• 技術の進歩：新しい製剤や送達方法など、ワクチン技術の革新が市場成長の原動力となっています。これらの進歩はワクチンの有効性と投与の容易性を高め、採用の増加と市場の拡大を支えています。
• ペット飼育率の上昇：世界のペット飼育数の増加が猫用ワクチンの需要を促進しています。ペットを飼い始め、ペットの健康を優先する人が増えるにつれ、効果的なワクチン接種ソリューションの必要性が高まり、市場の可能性を後押ししています。
• 予防ヘルスケアへの注力：ワクチン接種を含むペットの予防ヘルスケアが重視されるようになっています。この動向は、疾病予防におけるワクチン接種の重要性に対する意識の高まりを反映しており、市場の成長に寄与しています。

猫用ワクチン市場の課題は以下の通り：

• 規制上の課題：規制上の課題：ワクチンの安全性と有効性に関する厳しい規制要件は、メーカーにとって課題となります。これらの規制を乗り越え、コンプライアンスを確保することは、製品開発のタイムラインや市場参入に影響を与える可能性があります。
• 経済的制約：原材料コストの変動やワクチンの値ごろ感などの経済的要因は、市場力学に影響を与える可能性があります。メーカーは市場での競争力を維持するため、コストと品質のバランスをとる必要があります。

これらの促進要因・課題は、製品開発、市場開拓、規制遵守に影響を与え、猫用ワクチン市場を形成します。

目次

第1章 エグゼクティブサマリー

第2章 世界の猫用ワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の猫用ワクチン市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の猫用ワクチン市場：技術別
  • 弱毒生ワクチン
  • 結合ワクチン
  • 不活化ワクチン
  • サブユニットワクチン
  • トキソイドワクチン
  • DNAワクチン
  • 組み換えワクチン
• 世界の猫用ワクチン市場：年齢別
  • 6ヶ月未満
  • 6ヶ月以上
• 世界の猫用ワクチン市場：流通チャネル別
  • 獣医クリニック
  • ペットショップ
  • オンライン小売業者

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の猫用ワクチン市場：地域別
• 北米の猫用ワクチン市場
• 欧州の猫用ワクチン市場
• アジア太平洋の猫用ワクチン市場
• その他地域の猫用ワクチン市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の猫用ワクチン市場の成長機会：技術別
  • 世界の猫用ワクチン市場の成長機会：年齢別
  • 世界の猫用ワクチン市場の成長機会：流通チャネル別
  • 世界の猫用ワクチン市場の成長機会：地域別
• 世界の猫用ワクチン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の猫用ワクチン市場の生産能力拡大
  • 世界の猫用ワクチン市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Elanco Animal Health
• Boehringer Ingelheim
• Merck
• Zoetis
• Bioveta Lubricant Additives Company

The future of the global cat vaccine market looks promising with opportunities in the veterinary clinic, pet store, and online retailer channels. The global cat vaccine market is expected to reach an estimated $1.9 billion by 2031 with a CAGR of 7.2% from 2025 to 2031. The major drivers for this market are the rising cat ownership and the significant demand for vaccinations to prevent cat-transmitted diseases.

• Lucintel forecasts that, within the technology category, attenuated live will remain the largest segment due to their high efficiency and ability to stimulate both antibody and cellular immune responses.
• Within the distribution channel category, veterinary clinics are expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region due to strict government regulations regarding vaccination in protecting cats from serious diseases and the rising adoption of cats in the USA.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Cat Vaccine Market

The cat vaccine market is witnessing several emerging trends that reflect advancements in technology, shifts in consumer preferences, and evolving regulatory requirements.

• Increased Focus on Combination Vaccines: There has been a shift toward combination vaccines that protect against multiple diseases at once. Pet owners benefit from this since it is more convenient for them and reduces the number of veterinary visits, thereby enhancing overall vaccination compliance.
• Advancements in Vaccine Delivery Methods: Nasal inhalation and oral vaccines are being increasingly used. These innovations aim to reduce the stress associated with the vaccination of cats and make the process easier. As such, preventive healthcare may be boosted.
• Development of Personalized Vaccines: The market is seeing the development of personalized vaccines tailored to the specific health needs of individual cats. This trend aims to enhance vaccine efficacy and reduce the risk of adverse reactions, improving overall health outcomes.
• Growth of Preventive Healthcare: There is a growing emphasis on preventive healthcare for pets, including vaccinations. This trend reflects a shift toward proactive health management and increased awareness of the importance of vaccination in preventing diseases.
• Expansion into Emerging Markets: The cat vaccine market is expanding into emerging markets where pet ownership is increasing. Companies are focusing on providing affordable and effective vaccines to meet the growing demand in these regions.

These trends are reshaping the cat vaccine market by enhancing vaccine technology, improving accessibility, and promoting preventive care.

Recent Developments in the Cat Vaccine Market

Several critical developments demonstrate the growth of the cat vaccine industry in terms of technology, focus on feline health, and expanding market opportunities.

• Introduction of Combination Vaccines: New combination vaccines are being introduced that protect against several feline diseases with a single dose. This development helps increase the efficiency of vaccinations and makes it easier for pet owners and veterinarians to vaccinate pets.
• Advancement in Vaccine Delivery Systems: The simplicity of administering vaccines has been enhanced by advances in vaccine delivery systems, such as intranasal and oral vaccines. These innovations aim to reduce cats' stress levels and increase compliance with vaccination programs.
• Expansion of Vaccine Research: Increasing research endeavors are targeting emerging feline diseases and improving current vaccine formulations. This expansion addresses new health challenges while making vaccination more effective and safer.
• Growth in Market Accessibility: Efforts are underway to ensure increased accessibility of vaccines in regions with no access, driven by rising pet ownership rates and increased awareness of feline health. This development includes the introduction of affordable vaccines and expansion into rural areas.
• Personalized Vaccine Development: Personalized vaccines that match the medical requirements of individual cats are being created. This personalized approach ensures that vaccines work better, minimizing adverse reactions and providing better-targeted and safe vaccination options.

These advancements boost vaccine technology, expand research initiatives, enhance accessibility, and improve market reach toward developing cat vaccine products.

Strategic Growth Opportunities for Cat Vaccine Market

Market growth in cat vaccines offers many strategic opportunities for key applications, propelled by advancements in technology, increasing pet ownership, and awareness of feline health.

• Increasing Preventive Vaccination: Increasing preventive vaccination programs present growing opportunities. The rising awareness of the benefits of vaccines calls for increased coverage levels and reduced frequency of occurrence for cat diseases.
• Development of Advanced Vaccine Formulations: The new generation of vaccines, including combined and personalized vaccines, could open up a completely new market segment. These breakthroughs address specific health needs and improve vaccine efficacy, positively impacting market growth.
• Innovation in Vaccine Delivery Methods: New strategies, such as nasal sprays or oral vaccines, are being developed for vaccination. This is expected to result in better acceptance and administration rates, thereby raising the chances for this technology to become mainstream.
• Emerging Market Growth: Expanding into emerging markets where pet ownership is increasing provides considerable scope for expansion. Customizing solutions that fit these areas can help capture a larger share of this market space.
• Focus on Feline Health Research: Investment in research aimed at developing vaccines for emerging feline diseases holds growth potential. Addressing new health threats and improving existing vaccines can enhance market competitiveness and innovation.

These factors are shaping the cat vaccine market with an emphasis on preventive care, technological advancements, and expanding markets.

Cat Vaccine Market Driver and Challenges

The cat vaccine market is influenced by several drivers and challenges, such as technological advancements, economic factors, and regulatory changes. Therefore, understanding these elements is crucial for navigating the market landscape.

The factors driving the cat vaccine market include:

• Technological Advancements: Innovations in vaccine technology, including new formulations and delivery methods, are driving market growth. These advancements enhance vaccine efficacy and ease of administration, supporting increased adoption and market expansion.
• Rising Pet Ownership: Increasing pet ownership globally is driving demand for cat vaccines. As more people acquire pets and prioritize their health, the need for effective vaccination solutions is growing, boosting market potential.
• Focus on Preventive Healthcare: There is a growing emphasis on preventive healthcare for pets, including vaccination. This trend reflects increased awareness of the importance of vaccination in preventing diseases, contributing to market growth.

Challenges in the cat vaccine market include:

• Regulatory Challenges: Stringent regulatory requirements for vaccine safety and efficacy pose challenges for manufacturers. Navigating these regulations and ensuring compliance can impact product development timelines and market entry.
• Economic Constraints: Economic factors, such as fluctuations in raw material costs and the affordability of vaccines, can impact market dynamics. Manufacturers need to balance cost and quality to maintain competitiveness in the market.

These drivers and challenges shape the cat vaccine market by influencing product development, market growth, and regulatory compliance.

List of Cat Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cat vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cat vaccine companies profiled in this report include-

• Elanco Animal Health
• Boehringer Ingelheim
• Merck
• Zoetis
• Bioveta

Cat Vaccine by Segment

The study includes a forecast for the global cat vaccine market by technology, age, distribution channel, and region.

Cat Vaccine Market by Technology [Analysis by Value from 2019 to 2031]:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines

Cat Vaccine Market by Age [Analysis by Value from 2019 to 2031]:

• Below 6 Months
• Above 6 Months

Cat Vaccine Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

• Veterinary Clinics
• Pet Stores
• Online Retailers

Cat Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Cat Vaccine Market

Advancements in veterinary medicine, changing pet ownership trends, and increased awareness of animal health have led to the rapid evolution of the cat vaccine market. Recent advancements in this field indicate improvements in vaccine technology and feline health and safety efforts across various regions.

• United States: In the US, there has been significant progress with the introduction of new combination vaccines that can address multiple feline diseases in one shot. Improvements in vaccine formulations aim to enhance efficacy and reduce side effects. The market is also experiencing a transition toward longer-lasting immunity vaccines.
• China: China's focus is now on creating vaccines that combat emerging feline infections and improving existing immunization programs. There has been an upsurge in research activities within this market, supported by government initiatives for animal health and safety.
• Germany: Germany's market is progressing due to novel ways of delivering vaccines, such as intranasal or oral options for cats. These innovations aim to improve vaccination compliance and ease of administration. In addition, Germany seeks vaccines with broader protection against viral and bacterial infections.
• India: India requires cost-effective and efficient cat vaccines due to the rise in pet ownership and increased awareness of cat health issues across the country. Other developments include affordable vaccines whose coverage has been broadened into rural areas.
• Japan: In Japan, the market for cat vaccines has seen a revolution through personalized vaccinations tailored to the health status of individual cats. This involves creating effective vaccines that minimize harmful reactions, improving performance. Additionally, Japan is exploring new technologies for the production and distribution of vaccine products.

Features of the Global Cat Vaccine Market

Market Size Estimates: Cat vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Cat vaccine market size by technology, age, distribution channel, and region in terms of value ($B).

Regional Analysis: Cat vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, ages, distribution channels, and regions for the cat vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cat vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cat vaccine market by technology (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines), age (below 6 months and above 6 months), distribution channel (veterinary clinics, pet stores, and online retailers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cat Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Cat Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Cat Vaccine Market by Technology
  • 3.3.1: Attenuated Live Vaccines
  • 3.3.2: Conjugate Vaccines
  • 3.3.3: Inactivated Vaccines
  • 3.3.4: Subunit Vaccines
  • 3.3.5: Toxoid Vaccines
  • 3.3.6: DNA Vaccines
  • 3.3.7: Recombinant Vaccines
• 3.4: Global Cat Vaccine Market by Age
  • 3.4.1: Below 6 Months
  • 3.4.2: Above 6 Months
• 3.5: Global Cat Vaccine Market by Distribution Channel
  • 3.5.1: Veterinary Clinics
  • 3.5.2: Pet Stores
  • 3.5.3: Online Retailers

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Cat Vaccine Market by Region
• 4.2: North American Cat Vaccine Market
  • 4.2.1: North American Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.2.2: North American Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
• 4.3: European Cat Vaccine Market
  • 4.3.1: European Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.3.2: European Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
• 4.4: APAC Cat Vaccine Market
  • 4.4.1: APAC Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.4.2: APAC Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
• 4.5: ROW Cat Vaccine Market
  • 4.5.1: ROW Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.5.2: ROW Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cat Vaccine Market by Technology
  • 6.1.2: Growth Opportunities for the Global Cat Vaccine Market by Age
  • 6.1.3: Growth Opportunities for the Global Cat Vaccine Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Cat Vaccine Market by Region
• 6.2: Emerging Trends in the Global Cat Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cat Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cat Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Elanco Animal Health
• 7.2: Boehringer Ingelheim
• 7.3: Merck
• 7.4: Zoetis
• 7.5: Bioveta Lubricant Additives Company